Cystic Fibrosis: all 1,605 studies

Page 14 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• Study of Long-term Treatment With Hypertonic Saline in Patients With Cystic FibrosisCompletedNCT01377792Phase 4
• Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis PatientsCompletedNCT01375036
• Costimulatory Molecules as Biomarkers in Cystic FibrosisCompletedNCT01353950
• Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) ModulatorsCompletedNCT01348204Phase 2
• Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic FibrosisCompletedNCT01347190Phase 1
• A Study of Sweat Testing Using a Quantitative PatchCompletedNCT01345617
• Changes in Lung Function Based on Differences in Spirometry Equipment Used in Children With Cystic FibrosisCompletedNCT01343524
• Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic FibrosisStatus unknownNCT01337219Phase 1/2
• Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy ControlsCompletedNCT01331980
• Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) PatientsTerminatedNCT01329172Not applicable
• Study of Yoga as a Therapy for Cystic Fibrosis (CF) PatientsStatus unknownNCT01325766Not applicable
• Doxycycline Effects on Inflammation in Cystic FibrosisCompletedNCT01323101Phase 4
• Prospective Intervention Study on Vitamin D in Patients With Cystic FibrosisCompletedNCT01321905Not applicable
• A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic TherapiesCompletedNCT01319253
• Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas AeruginosaWithdrawnNCT01315691Phase 3
• Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and PlaceboStatus unknownNCT01309178Phase 2
• The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological PerspectiveCompletedNCT01306279
• Osteopathic Treatment in Adult Patients With Cystic FibrosisCompletedNCT01293019Phase 3
• Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®Status unknownNCT01288170Not applicable
• Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis PatientsCompletedNCT01285895
• Representations of Transplantation in Patients and in Health Care ProfessionalsCompletedNCT01285882
• Prevention of Bronchiectasis in Infants With Cystic FibrosisCompletedNCT01270074Phase 3
• Study of Individualized Physiotherapy for Airway Clearance in Cystic Fibrosis.CompletedNCT01266473Not applicable
• Sitagliptin in Cystic Fibrosis-Related DiabetesTerminatedNCT01257464Phase 2
• MD2Me - Texting to Promote Chronic Disease ManagementCompletedNCT01253733Not applicable
• Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant SuitabilityTerminatedNCT01241942Not applicable
• Prevention of CF Exacerbation in Childhood: PREVEC StudyCompletedNCT01241890
• The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in AdultsCompletedNCT01238081
• I Change Adherence & Raise ExpectationsCompletedNCT01232478Phase 3
• Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) PatientsWithdrawnNCT01229553Not applicable
• Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy SubjectsCompletedNCT01216046Phase 1
• Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy SubjectsCompletedNCT01208285Phase 1
• Circadian Rhythm In Tobramycin Elimination In Cystic FibrosisCompletedNCT01207245Phase 4
• Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic FibrosisTerminatedNCT01201434Not applicable
• Controlled Ventilation CT in CF InfantsTerminatedNCT01200888
• Sildenafil Trial in Children and Young Adults With CFWithdrawnNCT01194232Phase 1/2
• Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung DiseaseCompletedNCT01192360Phase 3
• CFfone: A Cell Phone Support Program for Adolescents With Cystic FibrosisStatus unknownNCT01183286Phase 2
• A Safety and Tolerability Study of Denufosol in 2-4 Year OldsCompletedNCT01181622Phase 2
• Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF)CompletedNCT01180842Phase 2
• Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic FibrosisCompletedNCT01172301Not applicable
• Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis PatientsTerminatedNCT01158937Not applicable
• Pulmozyme in Cystic Fibrosis With SinusitisWithdrawnNCT01155752Phase 3
• Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary DyskinesiaCompletedNCT01155115Not applicable
• Study of VX-770 on DesipramineCompletedNCT01153542Phase 1
• Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial InfectionCompletedNCT01150721
• Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional StudyCompletedNCT01150136
• Cystic Fibrosis (CF) Exacerbation and Insulin TreatmentStatus unknownNCT01149005Not applicable
• Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic FibrosisCompletedNCT01144507
• Molecular Phenotypes for Cystic Fibrosis Lung DiseaseCompletedNCT01116414
• Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS NebulizerCompletedNCT01116089Phase 1
• A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®CompletedNCT01111383Phase 3
• Cystic Fibrosis - Insulin Deficiency, Early ActionCompletedNCT01100892Phase 3
• Statins To Treat Adult Cystic FibrosisWithdrawnNCT01092572Phase 1/2
• Comparing Two Different Approaches in the Screening of Cystic Fibrosis Related DiabetesCompletedNCT01091025Not applicable
• Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. AeruginosaWithdrawnNCT01090908
• Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic RhinosinusitisCompletedNCT01086839Not applicable
• Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human SubjectsCompletedNCT01078740
• Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic FibrosisCompletedNCT01072721Not applicable
• Choline Nutrition in Children With Cystic FibrosisCompletedNCT01070446Not applicable
• Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770CompletedNCT01060566Phase 1
• High Frequency Chest Wall Oscillation and Cystic FibrosisCompletedNCT01057524Phase 3
• Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa InfectionCompletedNCT01055847Phase 2
• Glutamine Supplementation in Cystic FibrosisCompletedNCT01051999Phase 2
• Duration of Antibiotics in Infective Exacerbations of Cystic FibrosisStatus unknownNCT01044719Phase 4
• Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa ColonizationCompletedNCT01035853Phase 2
• A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)WithdrawnNCT01025713Phase 1
• Improving Adherence and Clinical Outcome in Cystic Fibrosis (CF) PatientsCompletedNCT01025258Not applicable
• Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)CompletedNCT01023048Not applicable
• Study of VX-770 and Rifampin in Healthy Male SubjectsCompletedNCT01018368Phase 1
• Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic FibrosisCompletedNCT01018303Phase 1/2
• Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) ExperienceCompletedNCT01013896Not applicable
• Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?TerminatedNCT01002534Phase 2
• A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy VolunteersCompletedNCT00999531Phase 1
• The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung FunctionTerminatedNCT00996424Phase 4
• Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic FibrosisApproved for marketingNCT00989807
• Standardisation of Measurements in Exhaled Breath and Exhaled Breath Condensate.Status unknownNCT00983671
• Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of LifeWithdrawnNCT00977158
• Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic FibrosisCompletedNCT00970346Phase 1
• Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic DiseaseCompletedNCT00967681Phase 3
• Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy SubjectsCompletedNCT00966602Phase 1
• Omega 3 Supplementation in Cystic Fibrosis PatientsCompletedNCT00959010Phase 3
• Microbial Community Composition and Metabolism in Cystic FibrosisCompletedNCT00954018
• A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCompletedNCT00951522Phase 1
• Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?CompletedNCT00945347Phase 2
• Oral Docosahexanoic Acid Supplementation in Cystic FibrosisCompletedNCT00924547Phase 2
• Structure and Function of Salivary ProteinsCompletedNCT00916682
• Cipro Inhaler for Cystic Fibrosis Children Ages 6-12CompletedNCT00910351Phase 1
• Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis PatientsStatus unknownNCT00908505Not applicable
• Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)CompletedNCT00906568
• Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis?CompletedNCT00890370Phase 4
• Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)CompletedNCT00889434Not applicable
• Fecal Calprotectin in Cystic FibrosisCompletedNCT00863694
• Early Intervention in Pulmonary Exacerbation in Cystic FibrosisCompletedNCT00850551Not applicable
• Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)TerminatedNCT00846781Phase 3
• RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis SputumCompletedNCT00843817Phase 4
• "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"CompletedNCT00840333Phase 1
• Airway Secretion Clearance in Cystic FibrosisTerminatedNCT00839644Not applicable
• Measurement of Lung Water by Transpulmonary Thermodilution in Lung Transplanted PatientsCompletedNCT00834054
• A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast MassesCompletedNCT00826488Early Phase 1

← Cystic Fibrosis overview